We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

MS Drug Could Reduce Painful Adverse Effects of Cancer Treatment

News   Apr 30, 2018 | Original story from Rockefeller University Press

 
MS Drug Could Reduce Painful Adverse Effects of Cancer Treatment

Compared with control animals (left), the spinal cords of rats treated with bortezomib (center) contain increased numbers of activated astrocytes (green) that cause neuropathic pain. Bortezomib's effects are prevented by the multiple sclerosis drug fingolimod (right), which inhibits the sphingolipid metabolite receptor S1PR1. Credit: Stockstill et al., 2018

 
 
 

RELATED ARTICLES

Evolutionary Connections Between Pregnancy and Cancer Metastasis

News

Scientists have used pregnancy to unlock a missing link between various species of mammals and cancer malignancy, changing the way we look at cancer metastasis.

READ MORE

E-cigarette User Found to Have Rare Form of Lung Scarring Typically Seen in Metal Workers

News

Researchers studying a patient with a rare lung disease called hard-metal pneumoconiosis believe that the disease may have been caused by vaping.

READ MORE

Could Stricter Alcohol Policies Help Reduce Cancer Deaths?

News

Scientists from Boston Medical Center and Boston University have revealed a new link between more restrictive alcohol policies and lower rates of cancer mortality.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Cancer Research Neuroscience

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE